Axcelis to Participate in the 28th Annual Needham Growth Conference

Rhea-AI Summary

Axcelis (NASDAQ: ACLS) announced that management will participate in the 28th Annual Needham Growth Conference on January 13, 2026 at The Lotte NY Palace Hotel in New York, NY.

Management is available for one-on-one and group meetings with investors during the conference, offering opportunities to discuss strategy and outlook with company executives.

Key Figures

Conference edition 28th 28th Annual Needham Growth Conference

Current price $92.99 Pre-news trading level for ACLS

Volume multiple 1.49x Today’s volume vs 20-day average

52-week high $102.93 Upper end of 52-week range before this news

52-week low $40.40 Lower end of 52-week range before this news

Price vs 52-week high -9.66% Distance from 52-week high prior to the conference news

Market cap $2,882,654,974 Equity value before conference announcement

Conference date January 13, 2026 Scheduled Needham conference participation

Market Reality Check

$93.10 Last Close

Volume Volume 737,025 is 1.49x the 20-day average of 495,560 ahead of the conference appearance. normal

Technical Shares at $92.99 are trading above the 200-day MA of $73.68 and about 9.66% below the 52-week high of $102.93.

Peers on Argus

ACLS was down 0.97% while key peers were mixed: FORM -0.18%, IPGP -3.57%, CAMT -0.39%, KLIC +2.39%, AMBA -11.62%. Moves do not indicate a unified sector direction.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Dec 10	Trade show showcase	Positive	+1.6%	Showcasing advanced ion implant solutions at SEMICON Japan 2025.
Nov 06	Investor conferences	Neutral	-2.7%	Announcement of participation in two upcoming investor conferences.
Nov 04	Q3 2025 earnings	Positive	-2.7%	Reported Q3 2025 results with strong EPS, cash and merger update.
Oct 22	Earnings timing	Neutral	-2.3%	Set timing and access details for Q3 2025 results call.
Oct 01	Merger announcement	Positive	-3.0%	Announced all-stock merger with Veeco to create larger equipment company.

Pattern Detected

Recent positive strategic and product news often saw negative or muted next-day reactions, especially around the Veeco merger and earnings.

Recent Company History

Over the last few months, Axcelis has focused on product showcasing, investor outreach, earnings, and a transformative merger. In October 2025, it announced an all-stock merger with Veeco, targeting a combined $1.7 billion revenue profile and $387 million adjusted EBITDA, but shares fell following the news. Q3 2025 results showed $213.6 million revenue and solid profitability, yet the stock again declined. Participation in industry events like SEMICON Japan 2025 and multiple investor conferences has been a recurring theme, similar in nature to today’s Needham conference announcement.

Market Pulse Summary

This announcement highlights Axcelis’ continued investor outreach, with management attending the 28th Annual Needham Growth Conference on January 13, 2026 for one-on-one and group meetings. It follows a series of events including trade shows, conference appearances, Q3 2025 earnings, and the Veeco merger announcement. Investors may focus on how management frames integration plans, market demand for ion implantation tools, and any qualitative commentary that builds on prior financial and strategic disclosures.

Key Terms

ion implantation technical

"a leading supplier of enabling ion implantation solutions for the semiconductor industry"

A manufacturing process that shoots tiny charged atoms into a solid material to change its electrical properties, most commonly used when making computer chips. Think of it like spraying microscopic seeds into a surface so parts of a circuit will conduct electricity differently; it directly affects product performance, production yield and cost. Investors watch it because advances or bottlenecks in this step can influence a maker’s competitiveness, output and profit margins.

AI-generated analysis. Not financial advice.

BEVERLY, Mass., Jan. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced management is scheduled to participate at the 28th Annual Needham Growth Conference on Tuesday, January 13th, 2026, at The Lotte NY Palace Hotel in New York, NY. Axcelis management will be available for one-on-one and group meetings with investors during the conference.

About Axcelis:
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

CONTACTS:

Investor Relations Contact:
David Ryzhik
Senior Vice President, Investor Relations and Corporate Strategy
Telephone: (978) 787-2352
Email: David.Ryzhik@axcelis.com

Press/Media Relations Contact:
Maureen Hart
Senior Director, Corporate & Marketing Communications
Telephone: (978) 787-4266
Email: Maureen.Hart@axcelis.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-to-participate-in-the-28th-annual-needham-growth-conference-302656131.html

SOURCE Axcelis Technologies, Inc.

FAQ

When will Axcelis (ACLS) participate in the Needham Growth Conference in 2026?

Axcelis management will participate on January 13, 2026 at the conference.

Where is the 28th Annual Needham Growth Conference where Axcelis (ACLS) will appear?

The conference will be held at The Lotte NY Palace Hotel in New York, NY.

Will Axcelis (ACLS) management meet with investors at the Needham Growth Conference?

Yes, management will be available for one-on-one and group meetings with investors during the conference.

How can investors request a meeting with Axcelis (ACLS) management at the Needham conference?

Investors should contact Axcelis investor relations to request meeting availability and scheduling details.

Does the Axcelis (ACLS) announcement include financial results or guidance at the Needham conference?

No financial results or guidance were included in the announcement; it states only management participation and investor meetings.

Is the Axcelis (ACLS) appearance at the Needham Growth Conference open to the public?

The announcement specifies investor meetings; public attendance details are determined by the conference organizer and registration.